Looks like no one added any tags here yet for you.
What are the 4 classes of antiplatelets?
Cyclooxygenase (COX) inhibitors aka NSAIDs
Phosphodiesterase inhibitors (PDE)
ADP receptor pathway inhibitors (ADP)
Glycoprotein IIb/IIIa antagonists
What is the ONLY NSAID used for antiplatelet therapy?
aspirin
Which of the following are PDE inhibitors?
SATA
a. Dipyridamole
b. Cilostazole
c. Abciximab
d. Clopidogrel
a,b
What are the 3 ADP receptor pathway inhibitors?
Clopidogrel
Prasugrel
Ticagrelor
Note: all have “grel” in the name
What are the 3 Glycoprotein IIb/IIIa antagonists?
Abciximab
Eptifibatide
Tirofiban
Which COX isoform deals with platelets?
a. COX1
b. COX2
a
Inhibiting COX1 will do what do platelet function? (increase/decrease)
decrease
What is the MOA of Aspirin?
covalently (irreversibly) binds to active site of COX1 and COX2
__________________ in cAMP leads to decrease in platelet activation and aggregation. (increase/decrease)
increase
think of cAMP as brakes to platelet aggregation
How can we increase cAMP?
inhibit platelet phosphodiesterases
(exactly why our drug class is called “Phosphodiesterase Inhibitors”)
Which PDE Inhibitor has an ADR of coronary steal syndrome?
Dipyridamole
Which PDE inhibitor can also be used for intermittent claudication?
Cilostazol
Which PDE inhibitor is contraindicated in heart failure?
Cilostazol
Which PDE inhibitor has a weak antiplatelet effect and is always combined with warfarin or aspirin?
Dipyridamole
Which PDE inhibitor has a high chance of CYP interactions?
Cilostazol
ADP receptor pathway inhibitors work by blocking what receptor?
P2Y12
If we block the P2Y12 receptor what happens?
ADP can’t bind= AC less inhibited= more cAMP= less platelet activation
What is the boxed warning on Clopidogrel (ADP Inhibitor)?
patients with 2C19 polymorphisms may have increased risk of CV events
Why can the 2C19 polymorphisms increase risk of CV events?
If your 2C19 doesn’t activate the drug, you have a clotting possibility
Boxed warning of Prasugrel and Ticagrelor:
bleeding risk-avoid in patients with history of TIA/stroke, active bleeding, severe hepatic impairment
Clopidogrel ____ a prodrug. Ticagrelor ______ a prodrug.
a. is, is
b. is, isn’t
c. isn’t, isn’t
d. isn’t, is
b
Which ADP inhibitors covalently(irreversibly) bind to the P2Y12 and which are competitive inhibitors?
Covalent- Clopidogrel, Prasugrel
Competitive- Ticagrelor
GP IIb/IIIa antagonists are all ___________________.
a. oral
b. parental
b
MOA of Abciximab (GP IIb/IIIa antagonist):
irreversibly bind GPIIb/IIIa receptor
uses steric effects
like “sitting on” on the GP IIb/IIIa receptor
What are the contraindications of Abciximab?
active internal bleeding
recent bleeding
thrombocytopenia
history of stroke
recent trauma/surgery
severe, uncontrolled HTN
Eptifibatide and Tirofiban bind _________________. (reversibly/irreversibly)
reversibly